SONOMA PHARMACEUTICALS, INC. Increase (Decrease) in Deferred Compensation
SONOMA PHARMACEUTICALS, INC. (SNOA) reported Increase (Decrease) in Deferred Compensation of $24.00 thousand for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInDeferredCompensation · last filed 2026-08-06
- SONOMA PHARMACEUTICALS, INC. increase (decrease) in deferred compensation for the quarter ending 2026-06-30 was $24.00K, a 56.36% decline year-over-year.
- SONOMA PHARMACEUTICALS, INC. increase (decrease) in deferred compensation for the quarter ending 2026-03-31 was $61.00K, a 17.31% increase year-over-year.
- SONOMA PHARMACEUTICALS, INC. increase (decrease) in deferred compensation for the quarter ending 2025-12-31 was $62.00K, a 44.19% increase year-over-year.
- SONOMA PHARMACEUTICALS, INC. increase (decrease) in deferred compensation for the quarter ending 2025-09-30 was $59.00K, a 28.26% increase year-over-year.
- SONOMA PHARMACEUTICALS, INC. increase (decrease) in deferred compensation for fiscal 2026 was $237.00K, a 22.16% increase from fiscal 2025.
- SONOMA PHARMACEUTICALS, INC. increase (decrease) in deferred compensation for fiscal 2025 was $194.00K, a 12.61% decline from fiscal 2024.
- SONOMA PHARMACEUTICALS, INC. increase (decrease) in deferred compensation for fiscal 2024 was $222.00K.
| Period end | Increase (Decrease) in Deferred Compensation 3 month | Increase (Decrease) in Deferred Compensation 6 month | Increase (Decrease) in Deferred Compensation 9 month | Increase (Decrease) in Deferred Compensation 12 month |
|---|---|---|---|---|
| 2026-06-30 | $24.00K 10-Q · filed 2026-08-06 | $85.00K derived: sum of 2 quarters · filed 2026-08-06 | $147.00K derived: sum of 3 quarters · filed 2026-08-06 | $206.00K derived: sum of 4 quarters · filed 2026-08-06 |
| 2026-03-31 | $61.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-06-16 | $123.00K derived: sum of 2 quarters · filed 2026-06-16 | $182.00K derived: sum of 3 quarters · filed 2026-06-16 | $237.00K 10-K · filed 2026-06-16 |
| 2025-12-31 | $62.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2026-02-10 | $121.00K derived: sum of 2 quarters · filed 2026-02-10 | $176.00K 10-Q · filed 2026-02-10 | $228.00K derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-09-30 | $59.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2025-11-04 | $114.00K 10-Q · filed 2025-11-04 | $166.00K derived: sum of 3 quarters · filed 2026-08-06 | $209.00K derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-06-30 | $55.00K 10-Q · filed 2026-08-06 | $107.00K derived: sum of 2 quarters · filed 2026-08-06 | $150.00K derived: sum of 3 quarters · filed 2026-08-06 | $196.00K derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-03-31 | $52.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-06-16 | $95.00K derived: sum of 2 quarters · filed 2026-06-16 | $141.00K derived: sum of 3 quarters · filed 2026-06-16 | $194.00K 10-K · filed 2026-06-16 |
| 2024-12-31 | $43.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2026-02-10 | $89.00K derived: sum of 2 quarters · filed 2026-02-10 | $142.00K 10-Q · filed 2026-02-10 | $203.00K derived: sum of 4 quarters · filed 2026-02-10 |
| 2024-09-30 | $46.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2025-11-04 | $99.00K 10-Q · filed 2025-11-04 | $160.00K derived: sum of 3 quarters · filed 2025-11-04 | $217.00K derived: sum of 4 quarters · filed 2025-11-04 |
| 2024-06-30 | $53.00K 10-Q · filed 2025-08-07 | $114.00K derived: sum of 2 quarters · filed 2025-08-07 | $171.00K derived: sum of 3 quarters · filed 2025-08-07 | |
| 2024-03-31 | $61.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-06-17 | $118.00K derived: sum of 2 quarters · filed 2025-06-17 | $222.00K 10-K · filed 2025-06-17 | |
| 2023-12-31 | $57.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-02-05 | $161.00K 10-Q · filed 2025-02-05 | ||
| 2023-09-30 | $104.00K 10-Q · filed 2024-11-07 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| enVVeno Medical Corp (NVNO) | United States | $0.006B | -0.48 |
| INTELLIGENT BIO SOLUTIONS INC. (INBS) | United States | $0.005B | |
| AETHLON MEDICAL INC (AEMD) | United States | $0.005B | |
| Co-Diagnostics, Inc. (CODX) | United States | $0.007B | -0.32 |
| Bluejay Diagnostics, Inc. (BJDX) | United States | $0.004B | |
| OSR Health, Inc. (OSRH) | United States | $0.004B | -0.75 |
| Adagio Medical Holdings, Inc. (ADGM) | United States | $0.004B | |
| Autonomix Medical, Inc. (AMIX) | United States | $0.004B | |
| Beyond Air, Inc. (XAIR) | United States | $0.003B | -0.01 |
| Vivos Therapeutics, Inc. (VVOS) | United States | $0.003B | -0.26 |